AzTrials
AzTrials

Mild Traumatic Brain InjuryReLoT-TCCLNCT04746716

Long Term Results of Psychoeducation and Cognitive Rehabilitation After Mild Traumatic Brain Injury

An observational study of Mild Traumatic Brain Injury, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Mild traumatic brain injury (mTBI) accounts for 70-90% of brain injuries, with 600 cases of mTBI per 100 000 people in the united states, but only 100-300 mTBI patients per 100 000 people receive hospital-based care. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Mild Traumatic Brain Injury
What is being tested?
Phone call
How many people
80 participants
Where
1 siteFrance
Study dates
2 Mar 2021to 2 Sep 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: 80 mild traumatic brain injured patients included in our previous study (NCT03811626)will be contacted by phone

Who may be able to join

  • all patients from our previous study NCT03811626 and included by our center
  • Patient informed and willing to participate

Who cannot join

  • Patient without social security

Trial locations and contacts

1 site in 1 country.

France1 site
  • AP-HP, Bicêtre Hospital

    Le Kremlin-Bicêtre, 94275

    Nozar AGHAKHANI, MD, PhD, +33(0)1 45 21 23 80, nozar.aghakhani@aphp.fr

Other trials in France

About this study

Mild traumatic brain injury (mTBI) accounts for 70-90% of brain injuries, with 600 cases of mTBI per 100 000 people in the united states, but only 100-300 mTBI patients per 100 000 people receive hospital-based care. Symptoms reported immediately after injury tend to diminish over the following 10 days and are generally resolved by 3 months. However, in 15-25% of cases , problems persist, and may even worsen, at 3 months. Physical, emotional, and behavioral factors can be affected. Physical disorders include pain and fatigue. Sleep disorders are also common. Persistent symptoms can affect patient outcomes (affecting all aspects of life) and increase public healthcare costs .In a previous study (NCT03811626, Efficacy of Psychoeducation and Cognitive Rehabilitation After Mild Traumatic Brain Injury for Preventing Post-concussional Syndrome in Individuals With High Risk of Poor Prognosis: A Randomized Clinical Trial. The investigators were able to demonstrate that early multidisciplinary management improved the outcome and prognosis of patients by statistically significantly reducing the percentage of patients with Post traumatic syndrome distress at six months (6% for the treated group versus 52% for the control group, p < 0.001).

It seems important to verify that if this short-term improvement (6 months after the trauma) persists in the long term, and therefore at a distance from the end of the initially proposed rehabilitation.

Read the detailed description

80 mTBI patients included in the previous study (NCT03811626) will be contacted by phone and an assessment consisting of questionnaires (QOLIBRI, SF-36, Posttraumatic stress disorder Checklist Scale (PCLS ) , ProQol) will be offered to them.

Being tested
Phone call
Keywords
mTBI, prognosis, rehabilitation, long term results
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Phone callOther

    Phone call to the patient to complete quality of life scales

Study groups in NCT04746716
Study groupRoleWhat they receive
Psychoeducation and Cognitive Rehabilitation After Mild Traumatic Brain InjuryPatient who had a psychoeducation and Cognitive Rehabilitation After their Mild Traumatic Brain Injury
Receives: Other: Phone call
No Psychoeducation and Cognitive Rehabilitation After Mild Traumatic Brain InjuryPatient who hadn't a psychoeducation and Cognitive Rehabilitation After their Mild Traumatic Brain Injury
Receives: Other: Phone call

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of the long term results of Psychoeducation and Cognitive Rehabilitation After Mild Traumatic Brain Injury

    quality of life questionnaire QOLIBRI (Quality of Life after Brain Injury). The QOLIBRI is a comprehensive questionnaire with 37 items covering six dimensions to assess health-related quality of life. Each items has to ba scaled from 1 (Not at all affected) to 5 (Very).The subscale scores can be used separately, or can be combined to give a profile of quality of life. All item responses can also be summed to give a total score.

    Measured: At inclusion = Day 1

Secondary outcomes (3)
  1. Contribution of knowledge on the epidemiology of Mild Traumatic Brain Injury

    quality of life questionnaire SF-36 : The 36-Item Short Form Survey (SF-36) is an oft-used, well-researched, self-reported measure of health. It stems from a study called the Medical Outcomes Study[1].

    It comprises 36 questions which cover eight domains of health. Scores for the different domains are converted and pooled using a scoring key, for a total score indicating a range of low to high quality of life

    Measured: At inclusion = Day 1

  2. Contribution of knowledge on the epidemiology of Mild Traumatic Brain Injury

    PCLS (Posttraumatic Stress Disorder Checklist Scale). 17 items rated from 1 (never) to 5 (Very often)

    Measured: At inclusion = Day 1

  3. Contribution of knowledge on the epidemiology of Mild Traumatic Brain Injury

    Professional Quality of Life Scale : The ProQOL has sub-scales for compassion satisfaction, burnout and compassion fatigue. There are 30questions rated from 1(Never) to 5(Very often)

    Measured: At inclusion = Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2021
  2. Study start2 Mar 2021 (estimated)
  3. Primary completion2 Sep 2021 (estimated)
  4. Study completion2 Sep 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04746716
Sponsor's protocol ID
APHP201206
Acronym
ReLoT-TCCL
Status last verified
Feb 2021
First submitted
19 Nov 2020
Last updated
2 Mar 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mild Traumatic Brain Injury, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nozar AGHAKHANI (33 1 45 21 23 80, nozar.aghakhani@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of the long term results of Psychoeducation and Cognitive Rehabilitation After Mild Traumatic Brain Injury (time frame: At inclusion = Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in